Literature DB >> 11730669

Efficacy of (123)N-isopropyl-p-[(123)I]-iodoamphetamine single photon emission computed tomography for the diagnosis of uveal malignant melanoma.

H Goto1, M Usui, I Ishii.   

Abstract

PURPOSE: To evaluate the efficacy of single photon emission computed tomography (SPECT) images with N-isopropyl-p-[(123)I]-iodoamphetamine ([(123)I]-IMP) as a radiopharmaceutical for the diagnosis of uveal melanoma.
METHODS: Consecutive interventional case series. Single photon emission computed tomography images were obtained after intravenous injection of [(123)I]-IMP in 20 patients with clinically suspected uveal melanoma (16 eyes of 16 patients) or ocular adnexal melanoma (four adnexal tumors of four patients). Histologic findings in seven eyes enucleated for uveal melanoma were analyzed with the SPECT images semiquantitatively evaluated.
RESULTS: Eight of 20 eyes with suspected uveal melanoma showed high accumulation of [(123)I]-IMP in the late phase in the area corresponding to the uveal tumor, and the diagnosis of uveal melanoma was confirmed histologically in seven enucleated eyes. Tumor size and histologic features did not reflect the intensity of scintillation counts of [(123)I]-IMP. Twelve patients with no accumulation on the SPECT images were found to have clinically or histologically iris nevus, choroidal nevus, and other intraocular and adnexal conditions.
CONCLUSION: N-isopropyl p-[(123)I]-iodoamphetamine SPECT may serve as a sensitive and specific examination for the diagnosis of uveal melanoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11730669     DOI: 10.1016/s0002-9394(01)01142-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  Diagnosis of atypical choroidal malignant melanoma using N-isopropyl-p-[123I]-iodoamphetamine single photon emission computed tomography.

Authors:  Toshinobu Kubota; Katsuhiko Kato; Shu Ichihara; Hiroshi Hirose
Journal:  Jpn J Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 2.447

2.  A case of iris melanocytoma transformed to malignant melanoma.

Authors:  Ryo Inoue; Yoshitsugu Saishin; Chiharu Shima; Hiroshi Yoshikawa; Nobuyuki Ohguro; Yasuo Tano
Journal:  Jpn J Ophthalmol       Date:  2009-05-31       Impact factor: 2.447

3.  Noninvasive diagnostics supporting system for choroidal melanoma: a pilot study.

Authors:  Ori Kameyama; Yoshihiko Usui; Keisuke Kimura; Atsushi Nakamura; Takayuki Sota; Hiroshi Goto
Journal:  Jpn J Ophthalmol       Date:  2014-10-08       Impact factor: 2.447

4.  Immunoglobulin G4-Related Ophthalmic Disease Involving the Sclera Misdiagnosed as Intraocular Tumor: Report of One Case.

Authors:  Hiroshi Goto; Shunichiro Ueda
Journal:  Ocul Oncol Pathol       Date:  2016-08-04

5.  Perivascular Epithelioid Cell Tumor Arising from Ciliary Body Treated by Local Resection.

Authors:  Hiroshi Goto; Yoshihiko Usui; Toshitaka Nagao
Journal:  Ocul Oncol Pathol       Date:  2014-11-21

6.  Treatment of large conjunctival nevus by resection and reconstruction using amniotic membrane.

Authors:  Machiko Tomita; Hiroshi Goto; Ryuji Muramatsu; Masahiko Usui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-11-29       Impact factor: 3.117

7.  Iris Melanoma in a Patient with Retinitis Pigmentosa.

Authors:  Hiroshi Goto; Naoyuki Yamakawa
Journal:  Ocul Oncol Pathol       Date:  2021-05-27

8.  Clinicopathological correlation for the role of fluorodeoxyglucose positron emission tomography computed tomography in detection of choroidal malignant melanoma.

Authors:  Toshihiko Matsuo; Yuka Ogino; Kouichi Ichimura; Takehiro Tanaka; Mitsumasa Kaji
Journal:  Int J Clin Oncol       Date:  2013-03-01       Impact factor: 3.402

9.  Histopathology and immunohistochemistry of choroidal melanocytoma demonstrated by local resection: A case report.

Authors:  Hiroshi Goto; Naoyuki Yamakawa; Hiroyuki Komatsu
Journal:  Am J Ophthalmol Case Rep       Date:  2021-06-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.